Spondyloarthritis & psoriatic arthritis

Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in spondyloarthritis (SpA): findings from the DEUS multicentre study

Semin Arthritis RheumPublished Cross-sectional study

Authors' conclusion

This study reveals a high prevalence of ultrasound-detected structural damage at the enthesis and identifies distinct SpA phenotypes based on these findings.

Study context

Population
Patients with SpA, 20 rheumatology centres (DEUS study); US of large lower limb entheses
Participants
413 SpA patients
Exposure
Axial spondyloarthritis (axSpA) vs psoriatic arthritis (PsA)
  • axSpAn = 224
  • PsAn = 189
Outcome
Prevalence and distribution of US-detected entheseal structural lesions (bone erosions, enthesophytes, calcifications; OMERACT definitions)
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Prevalence of entheseal structural lesions in SpA

Enthesophytes (most common lesion)

78.7 %

Calcifications

43.6 %

Bone erosions

24.9 %

Observational data: associations, not effects.

Further findings

Enthesophytes, PsA vs axSpA

P < 0.001

Erosions and calcifications, PsA vs axSpA

No significant differences in erosions and calcifications

Factors associated with lesions (multivariate logistic regression)

Erosions associated with inflammatory markers, HLA-B27 positivity, clinical enthesitis and longer disease duration
Enthesophytes linked to PsA, psoriasis, clinical enthesitis and longer disease duration
Calcifications associated with hypertension, metabolic syndrome and obesity
All lesions associated with bDMARD use

Original publication

Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study. Semin Arthritis Rheum. Published 28 August 2025. doi:10.1016/j.semarthrit.2025.152823

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.